Readiness for Bispecific Antibody Therapy: Initiation and Maintenance Phases

Financial Affordability and SustainabilityCancer care may create financial hardship for patients.It is critical for the cancer care team to assess needs throughout the care journey, connecting patients and their caregivers with team members who can help to navigate financial barriers and identify available financial assistance programs.Novel innovative therapies are often not fully covered by insurance providers and in some cases, may not be covered at all.Provider organizations should establish a process to verify benefits and secure any necessary prior authorizations.This ensures potential barriers or coverage gaps for BsAbs and supportive care medications are identified early and addressed promptly, minimizing any treatment delays. Patient and Caregiver Education and EngagementPatients and caregivers must be informed about the potential adverse events related to BsAb treatment.Education should review strategies for preventing toxicities and how symptoms will be managed if they occur.Useful resources include patient wallet cards, emergency contact numbers, and a list of symptoms to monitor.Equally important is ensuring that cancer care team members stay up to date on the latest recommendations and guidelines for preventing and managing toxicities that may result from BsAb treatment. Key principles include promoting

Publication Details

Journal
Oncology Issues
Published
2024-12-01
DOI
https://doi.org/10.3928/25731777-20241213-09
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Readiness for Bispecific Antibody Therapy: Initiation and Maintenance Phases

Oncology Issues
Monoclonal and Polyclonal Antibodies Research
article

Readiness for Bispecific Antibody Therapy: Initiation and Maintenance Phases

article en

Abstract

Financial Affordability and SustainabilityCancer care may create financial hardship for patients.It is critical for the cancer care team to assess needs throughout the care journey, connecting patients and their caregivers with team members who can help to navigate financial barriers and identify available financial assistance programs.Novel innovative therapies are often not fully covered by insurance providers and in some cases, may not be covered at all.Provider organizations should establish a process to verify benefits and secure any necessary prior authorizations.This ensures potential barriers or coverage gaps for BsAbs and supportive care medications are identified early and addressed promptly, minimizing any treatment delays. Patient and Caregiver Education and EngagementPatients and caregivers must be informed about the potential adverse events related to BsAb treatment.Education should review strategies for preventing toxicities and how symptoms will be managed if they occur.Useful resources include patient wallet cards, emergency contact numbers, and a list of symptoms to monitor.Equally important is ensuring that cancer care team members stay up to date on the latest recommendations and guidelines for preventing and managing toxicities that may result from BsAb treatment. Key principles include promoting

Oncology IssuesVol. 39(6)
Openalex Percentile: Top 60%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Readiness for Bispecific Antibody Therapy: Initiation and Maintenance Phases · Oncology Issues (2024) | TGRS Research Map | TGRS